Prenatal cannabis exposure linked to increased risk of opioid addiction later in life

With the increased legalization of recreational cannabis, as many as 1 in 5 pregnant women in the U.S. are now using the drug to help with morning sickness, lower back pain or anxiety.

Study analyzes the similarities between near-death experiences and psychedelic experiences

Researchers analyzed the similarities and differences between a near-death experience (NDE) while in a coma and the experience induced by a psychedelic drug.

July 28, 2023

argenx wins EMA CHMP nod for subcutaneous Vyvgart in myasthenia gravis – Pharmaceutical Technology

Vyvgart is argenx’s high-grossing drug, having generated $269m in Q2 2023. Image Credit: Kateryna Kon / Shutterstock. The Committee for Medicinal Products for Human Use

September 15, 2023

Ancient Eastern Arabians developed malaria resistance through agriculture, study finds

People living in ancient Eastern Arabia appear to have developed resistance to malaria following the appearance of agriculture in the region around five thousand years

February 27, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.